Autofluorescence of skin advanced glycation end products: Marker of metabolic memory in elderly population

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 7, 2015, Pages 841-846

  Rajaobelina, Kalina ^a,b   Cougnard Gregoire, Audrey ^a,b   Delcourt, Cecile ^a,b   Gin, Henri ^c   Barberger Gateau, Pascale ^a,b   Rigalleau, Vincent ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Advanced glycation end products; Aging; Metabolic memory; Skin autofluorescence

Indexed keywords

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CREATININE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED;

AGED; AGED, 80 AND OVER; BLOOD; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; METABOLISM; OPTICAL IMAGING; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SKIN; TIME FACTORS;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OPTICAL IMAGING; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SKIN; TIME FACTORS;

EID: 84936776401     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu243     Document Type: Article

References (31)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813-820. doi: 10.1038/414813a
2. Bianchi C, Miccoli R, Del Prato S. Hyperglycemia and vascular metabolic memory: truth or fiction?. Curr Diab Rep. 2013; 13: 403-410. doi: 10.1007/s11892-013-0371-2
3. Hanssen NM, Engelen L, Ferreira I, et al. Plasma levels of advanced glycation endproducts Ne-(carboxymethyl)lysine, Ne-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. J Clin Endocrinol Metab. 2013; 98: E1369-E1373. doi: 10.1210/jc.2013-1068
4. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000; 275: 39027-39031. doi: 10.1074/jbc.M006700200
5. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004; 47: 1324-1330. doi: 10.1007/s00125-004-1451-2
6. Genuth S, Sun W, Cleary P, et al. Skin advanced glycation endproducts (AGEs) glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type I diabetes. Diabetes. 2014; 64: 266-278. doi: 10.2337/db14-0215
7. Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype?. J Gerontol A Biol Sci Med Sci. 2010; 65: 963-975. doi: 10.1093/gerona/glq074
8. Koyama H, Nishizawa Y. AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?. Eur J Clin Invest. 2010; 40: 623-635. doi: 10.1111/j.1365-2362.2010.02298.x
9. LifeLines Cohort Study Group, DCCT/EDIC Research Group, Eny KM, et al. GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia. 2014; 57: 1623-1634. doi: 10.1007/s00125-014-3286-9
10. Rosner M, Abdel-Rahman E, Williams ME. Geriatric nephrology: responding to a growing challenge. Clin J Am Soc Nephrol. 2010; 5: 936-942. doi: 10.2215/CJN.08731209
11. 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003; 22: 316-325. doi: 10.1159/000072920
12. Delcourt C, Korobelnik JF, Barberger-Gateau P, et al. Nutrition and agerelated eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study. J Nutr Health Aging. 2010; 14: 854-861. doi: 10.1007/s12603-010-0131-9
13. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553. doi: 10.1002/(SICI)1096-9136(199807)15: 73.0.CO; 2-S
14. Levey AS, De Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80: 17-28. doi: 10.1038/ki.2010.483
15. Kouidrat Y, Amad A, Desailloud R, et al. Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia. J Psychiatr Res. 2013; 47: 1044-1048. doi: 10.1016/j.jpsychires.2013.03.016
16. den Engelsen C, van den Donk M, Gorter KJ, Salome PL, Rutten GE. Advanced glycation end products measured by skin autofluorescence in a population with central obesity. Dermatoendocrinol. 2012; 4: 33-38. doi: 10.4161/derm.17999
17. Aroda VR, Conway BN, Fernandez SJ, et al. Cross-sectional evaluation of noninvasively detected skin intrinsic fluorescence and mean hemoglobin a1c in type 1 diabetes. Diabetes Technol Ther. 2013; 15: 117-123. doi: 10.1089/dia.2012.0211
18. Felipe DL, Hempe JM, Liu S, et al. Skin intrinsic fluorescence is associated with hemoglobin A(1c)and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care. 2011; 34: 1816-1820. doi: 10.2337/dc11-0049
19. Sugisawa E, Miura J, Iwamoto Y, Uchigata Y. Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes. Diabetes Care. 2013; 36: 2339-2345. doi: 10.2337/dc12-1077
20. Genevieve M, Vivot A, Gonzalez C, et al. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus. Diabetes Metab. 2013; 39: 349-354. doi: 10.1016/j.diabet. 2013.03.003
21. Chabroux S, Canoui-Poitrine F, Reffet S, et al. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab. 2010; 36: 152-157. doi: 10.1016/j.diabet.2009.11.003
22. Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006; 29: 2654-2659. doi: 10.2337/dc05-2173
23. Tanaka K, Tani Y, Asai J, et al. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes: skin advanced glycation end products and diabetic vascular complications. Diabet Med. 2012; 29: 492-500. doi: 10.1111/j.1464-5491.2011.03448.x
24. Gerrits EG, Lutgers HL, Kleefstra N, et al. Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9). J Diabetes Sci Technol. 2008; 2: 572-577. doi: 10.1177/193229680800200407
25. Hu H, Han CM, Hu XL, Ye WL, Huang WJ, Smit AJ. Elevated skin autofluorescence is strongly associated with foot ulcers in patients with diabetes: a cross-sectional, observational study of Chinese subjects. J Zhejiang Univ Sci B. 2012; 13: 372-377. doi: 10.1631/jzus.B1100249
26. Noordzij MJ, Mulder DJ, Oomen PH, et al. Skin autofluorescence and risk of micro-and macrovascular complications in patients with type 2 diabetes mellitus-a multi-centre study. Diabet Med. 2012; 29: 1556-1561. doi: 10.1111/dme.12005
27. Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16: 3687-3693. doi: 10.1681/ASN.2005020144
28. McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol. 2011; 6: 2356-2363. doi: 10.2215/CJN.02420311
29. Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes. 2012; 61: 549-559. doi: 10.2337/db11-1120
30. Murata K, Baumann NA, Saenger AK, Larson TS, Rule AD, Lieske JC Relative performance of the MDRD and CKD-EPI equations for estimating glomerular filtration rate among patients with varied clinical presentations. Clin J Am Soc Nephrol. 2011; 6: 1963-1972. doi: 10.2215/CJN.02300311
31. Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014; 174: 251-258. doi: 10.1001/jamainternmed.2013.12956